Katsuta K - Search Results

1

[A randomized controlled study of adjuvant immunotherapy with N-CWS for head and neck malignancies].

Sakai S, Itoh M, Matsunaga T, Yoshida J, Sato T, Miyahara Y, Matsunaga T, Hyoh Y, Ohyama K, Katsuta K, et al. Sakai S, et al. Among authors: katsuta k. Gan No Rinsho. 1985 Sep;31(11):1353-61. Gan No Rinsho. 1985. PMID: 4068237 Clinical Trial. Japanese.

2

[A comparative study of UFT enteric-coated granules with UFT capsules on the occurrence of side effects in patients with head and neck cancers--a special attention to the upper gastrointestinal tract disorders].

Ohyama M, Matsumura M, Katsuta K, Nobori T, Matsuyama H, Fukami K, Kiyota R, Yano H, Shima T, Ogawa K, et al. Ohyama M, et al. Among authors: katsuta k. Gan To Kagaku Ryoho. 1990 Jun;17(6):1211-6. Gan To Kagaku Ryoho. 1990. PMID: 2112372 Japanese.

3

[A phase II study of Futraful suppository in head and neck cancer].

Ohyama M, Matsumura M, Katsuta K, Nobori T, Furuta S, Matsunaga S, Uchizono A, Hanada T, Moriyama I, Kamachi S, et al. Ohyama M, et al. Among authors: katsuta k. Gan To Kagaku Ryoho. 1988 Jul;15(7):2093-100. Gan To Kagaku Ryoho. 1988. PMID: 3134860 Japanese.

4

Protective effect of FR35447 on experimental cerebral infarction.

Kamitani T, Katsuta K, Sakai S, Sakata Y, Motoyama Y, Horiai H, Ono T, Kikuchi H, Kumada S. Kamitani T, et al. Among authors: katsuta k. Arch Int Pharmacodyn Ther. 1984 Dec;272(2):264-76. Arch Int Pharmacodyn Ther. 1984. PMID: 6441533

5

Studies on cerebral protective agents. I. Novel 4-arylpyrimidine derivatives with anti-anoxic and anti-lipid peroxidation activities.

Kuno A, Sugiyama Y, Katsuta K, Kamitani T, Takasugi H. Kuno A, et al. Among authors: katsuta k. Chem Pharm Bull (Tokyo). 1992 Jun;40(6):1452-61. doi: 10.1248/cpb.40.1452. Chem Pharm Bull (Tokyo). 1992. PMID: 1394663

6

Mechanism(s) of the hypotensive effect of synthetic 1-O-octadecyl-2-O-acetyl-glycero-3-phosphorylcholine.

Kamitani T, Katamoto M, Tatsumi M, Katsuta K, Ono T, Kikuchi H, Kumada S. Kamitani T, et al. Among authors: katsuta k. Eur J Pharmacol. 1984 Mar 2;98(3-4):357-66. doi: 10.1016/0014-2999(84)90284-x. Eur J Pharmacol. 1984. PMID: 6144557

7

[Clinical studies of S6472 in otorhinolaryngologic infections].

Baba S, Kinoshita H, Mori Y, Suzuki K, Ohyama M, Katsuta K, Furuta S, Ohno I, Noboru T, Yamamoto M, et al. Baba S, et al. Among authors: katsuta k. Jpn J Antibiot. 1985 Jul;38(7):1750-60. Jpn J Antibiot. 1985. PMID: 4068219 Japanese.

8

Studies on cerebral protective agents. II. Novel 4-arylpyrimidine derivatives with anti-anoxic and anti-lipid peroxidation activities. (2).

Kuno A, Sugiyama Y, Katsuta K, Sakai H, Takasugi H. Kuno A, et al. Among authors: katsuta k. Chem Pharm Bull (Tokyo). 1992 Sep;40(9):2423-31. doi: 10.1248/cpb.40.2423. Chem Pharm Bull (Tokyo). 1992. PMID: 1446365

9

Studies on cerebral protective agents. III. Novel 4-arylpyrimidine derivatives with anti-anoxic and anti-lipid peroxidation activities. (3).

Kuno A, Katsuta K, Sakai H, Ohkubo M, Sugiyama Y, Takasugi H. Kuno A, et al. Among authors: katsuta k. Chem Pharm Bull (Tokyo). 1993 Jan;41(1):139-47. doi: 10.1248/cpb.41.139. Chem Pharm Bull (Tokyo). 1993. PMID: 8448814

10

Studies on cerebral protective agents. IX. Synthesis of novel 1,2,3,4-tetrahydroisoquinolines as N-methyl-D-aspartate antagonists.

Ohkubo M, Kuno A, Katsuta K, Ueda Y, Shirakawa K, Nakanishi H, Nakanishi I, Kinoshita T, Takasugi H. Ohkubo M, et al. Among authors: katsuta k. Chem Pharm Bull (Tokyo). 1996 Jan;44(1):95-102. doi: 10.1248/cpb.44.95. Chem Pharm Bull (Tokyo). 1996. PMID: 8582046

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85 results

Search Page

Filters